The EU-funded project REBECCA taps into the potential of Real-World Data to support clinical research and to improve existing clinical workflows.
It will combine clinical data with data obtained from multiple wearable, online behaviour and registry data to study the complex array of chronic comorbidities developed during breast cancer recovery. The data will be deployed within 7 clinical studies in 3 countries, involving over 650 individuals, and it will help shape future guidelines and practices for post-cancer treatment.
Sign up to our newsletter
Sign up for our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
More impact of clinical research on breast cancer patients
Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment. Best practices from the REBECCA studies will be disseminated to researchers, public health and regulatory bodies throughout Europe to facilitate wider adoption of RWD in clinical research.
REBECCA will provide an infrastructure for continued progress on the use of RWD beyond the project, facilitating the mass adoption of RWD as a valuable clinical research and patient management tool.
Find Out More
How we will do it
Our work packages are evolving, but include consideration and development of:
Find out about the latest REBECCA related news.
Towards better stakeholder engagement: looking back to the World Cancer Day 2023 results
This year’s World Cancer Day campaign with a catchy slogan “Close The Care Gap” among other things, provided an in-depth look at the socioeconomic factors, such as cultural contexts, gender norms, income and education levels, as well as the prejudices, discrimination and assumptions based on age,…
World Cancer Day 2023 is approaching! The REBECCA Project Team is Excited to Support the Cause!
Cancer is a devastating disease that continues to impact the lives of millions of people across the globe. Although cancer can be treated and managed, many patients and their loved ones often feel overwhelmed in the aftermath of such a diagnosis. Cancer treatments can be a long and challenging jo…
Introduction to the REBECCA Case Report Form
As of 2022, breast cancer is the most common form of cancer among women worldwide. Following their primary cancer treatment, women are facing significant challenges in their lives. These include physical symptoms, such as pain or fatigue, as well as emotional symptoms, including fear of cancer re…
The project brings together 12 partners from 7 European countries. Clinical and technological universities, industry leaders, public health experts, and patient associations will work together to shape guidelines and practices for post-cancer treatment.